The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels
- 1 April 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (4) , 775-780
- https://doi.org/10.1046/j.1365-2133.2001.04132.x
Abstract
Background Pemphigus vulgaris (PV) and foliaceus (PF) are characterized by antibodies to the desmosomal proteins desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1), respectively. Past studies using indirect immunofluorescence (IIF) as a measure of pemphigus antibody levels have failed to demonstrate consistently a relationship between disease severity and IIF titres. However, IIF is not able to measure separately Dsg1 and 3 antibodies, unlike enzyme-linked immunosorbent assays (ELISA), which utilize recombinant proteins. Objectives To compare independently Dsg1 and 3 antibody levels with the severity of both cutaneous and oral involvement in PV and PF. Patients and methods Four hundred and twenty-four serum samples were analysed from 80 subjects with PV and 24 with PF. IgG antibodies to Dsg1 and 3 were measured by ELISA. For every sample analysed, the associated severity of skin and oral disease were graded from 0 to 3; quiescent, mild, moderate and severe. Results A relationship between Dsg1 antibodies and skin severity was demonstrated such that a 10-unit increase in Dsg1 ELISA value was associated with a 34% chance of having a higher severity score [95% confidence interval (CI), 25–45%, P < 0·0005]. This was observed in both PV and PF. Oral severity was associated with Dsg3 antibody levels and a 10-unit increase in the Dsg3 ELISA value was associated with a 25% chance of a higher oral severity score (CI 17–33%, P < 0·0005). We were unable to demonstrate a relationship between Dsg1 antibodies and oral severity, even after adjusting for the effect of Dsg3 antibodies. Similarly, there was no relationship between Dsg3 antibodies and skin severity. Conclusions This study suggests that the clinical phenotype of pemphigus, in particular the balance of skin and oral disease, is determined principally by the quantities of Dsg1 and 3 autoantibodies, respectively.Keywords
This publication has 45 references indexed in Scilit:
- The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relativesBritish Journal of Dermatology, 2000
- The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigusBritish Journal of Dermatology, 2000
- Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3Clinical and Experimental Dermatology, 2000
- Antibodies to desmoplakin in a patient with pemphigus foliaceousJournal of the European Academy of Dermatology and Venereology, 1998
- Prevalence of bands other than 160 and 130 kDa in pemphigus sera (a multicenter immunoblotting study)Journal of the European Academy of Dermatology and Venereology, 1998
- Circulating pemphigus IgG in families of patients with pemphigus: Comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblottingPublished by Elsevier ,1997
- IgG subclasses in pemphigus in Indian and UK populationsClinical and Experimental Dermatology, 1993
- Presence of the autoantibody in healthy relatives of Italian patients with pemphigus vulgarisArchives of Dermatological Research, 1993
- Determination of IgG subclasses in patients with pemphigus with active disease and in remissionArchives of Dermatology, 1989
- Comparison of Different Epithelial Substrates Useful for Indirect Immunofluorescence Testing of Sera from Patients with Active PemphigusJournal of Investigative Dermatology, 1979